This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Lopinavir + ritonavir followed by nevirapine “optimal ART strategy”. Pharmacoecon. Outcomes News 506, 6 (2006). https://doi.org/10.2165/00151234-200605060-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605060-00013